|
1）Cawthon RM, Smith KR, OBrien E, et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003; 361(9355): 393-5
|
|
|
|
2）Liu B, Wang J, Chan KM, et al. Genomic instability in laminopathy-based premature aging. Nat Med. 2005; 11(7): 780-5
|
|
|
|
|
|
3）Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007; 100(1): 15-26
|
|
|
|
|
|
4）Minamino T, Komuro I. Vascular aging: insights from studies on cellular senescence, stem cell aging, and progeroid syndromes. Nat Clin Pract Cardiovasc Med. 2008; 5(10): 637-48
|
|
|
|
|
|
5）Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121): 860-7
|
|
|
|
|
|
6）Nishimura S, Manabe I, Nagasaki M, et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med. 2009; 15(8): 914-20
|
|
|
|
|
|
7）Charo IF. Macrophage polarization and insulin resistance: PPARgamma in control. Cell Metab. 2007; 6(2): 96-8
|
|
|
|
|
|
8）Weisberg SP, McCann D, Desai M, et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003; 112(12): 1796-808
|
|
|
|
|
|
9）Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature. 2006; 444(7121): 881-7
|
|
|
|
|
|
10）Minamino T, Orimo M, Shimizu I, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med. 2009; 15(9): 1082-7
|
|
|
|
|
|
11）Wessells RJ, Fitzgerald E, Cypser JR, et al. Insulin regulation of heart function in aging fruit flies. Nat Genet. 2004; 36(12): 1275-81
|
|
|
|
|
|
12）Shimizu I, Minamino T, Toko H, et al. Excessive cardiac insulin signaling exacerbates systolic dysfunction induced by pressure overload in rodents. J Clin Invest. 2010; 120(5): 1506-14
|
|
|
|
|
|
13）Ashrafian H, Frenneaux MP, Opie LH. Metabolic mechanisms in heart failure. Circulation. 2007; 116(4): 434-48
|
|
|
|
|
|
14）Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circulation research. 2007; 101(4): 335-47
|
|
|
|
|
|
15）Witteles RM, Fowler MB. Insulin-resistant cardiomyopathy clinical evidence, mechanisms, and treatment options. Am Coll Cardiol. 2008; 51(2): 93-102
|
|
|
|
|
|
16）Ingelsson E, Sundstrom J, Arnlov J, et al. Insulin resistance and risk of congestive heart failure. JAMA. 2005; 294(3): 334-41
|
|
|
|
|
|
17）Arnlov J, Lind L, Zethelius B, et al. Several factors associated with the insulin resistance syndrome are predictors of left ventricular systolic dysfunction in a male population after 20 years of follow-up. Am Heart J. 2001; 142(4): 720-4
|
|
|
|
|
|
18）Shimizu I, Yoshida Y, Katsuno T, et al. p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab. 2012; 15(1): 51-64
|
|
|
|
|